From prayer times to family vigils, everyday realities can alter how delirium presents — and how clinicians should respond.

The Sunnyvale, CA-based firm's EEG-based solution uses artificial intelligence algorithms to identify large vessel occlusion ...

Ceribell wins FDA Breakthrough status for its AI-driven EEG solution to detect and monitor LVO strokes in hospitals, boosting credibility and growth outlook.

Ceribell announced today that the FDA granted breakthrough device designation for its large vessel occlusion (LVO) stroke ...

Ceribell’s LVO Stroke tool is underpinned by the same EEG monitoring technology used in its seizure and delirium monitoring ...

Clearance would position the Ceribell System as the first and only point-of-care electroencephalography (EEG) technology to ...

Let’s be clear. The primary reason to be vaccinated against shingles is that two shots provide 90 percent protection against ...

Lee Fleisher oversaw the development of the ‘hospital at home’ CMS waiver. Congress must update the program, he writes.

Investing.com -- CeriBell, Inc. (NASDAQ:CBLL) stock jumped 8% on Monday after the medical technology company announced it received FDA Breakthrough Device Designation for its Large Vessel Occlusion ...

CeriBell (CBLL) announced that the U.S. Food and Drug Administration has granted Breakthrough Device Designation for its Large Vessel Occlusion ...

The Cellares Cell Shuttle platform was the first to receive the FDA’s Advanced Manufacturing Technology (AMT) designation, which offers partners additional touchpoints and priority review mechanisms ...

CeriBell, Inc. (NASDAQ:CBLL) shares climbed 8% on Monday after the company said it had received Breakthrough Device ...